Enlivex Therapeutics
ENLV
ENLV
15 hedge funds and large institutions have $1.24M invested in Enlivex Therapeutics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
2
Closed
4
Calls
$188K
Puts
$232K
Net Calls
-$44K
Net Calls Change
-$96K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$184K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$152K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$69K |
| 4 |
Renaissance Technologies
New York
|
+$29.6K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$27.4K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$63.7K |
| 2 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$35.1K |
| 3 |
Citigroup
New York
|
-$12.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.25K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$718 |
